1200P A Phase II Single-Arm Interventional Trial Evaluating the Activity and Safety of CABOzantinib (CBZ) Plus TEMozolomide (TMZ) in Lung and Gastroenteropancreatic Neuroendocrine Neoplasms (Gep-Nens) Progressed after SSA Therapy, Everolimus, Sunitinib or PRRT: CABOTEM Trial
ANNALS OF ONCOLOGY（2023）
Key words
Neoadjuvant Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined